10-Q 季报仅提供 GAAP 数据
| 指标 | Q3 FY2024 | Q2 FY2024 | Q/Q | Q3 FY2023 | Y/Y |
|---|---|---|---|---|---|
| 营收 Revenue | $6,811M | $5,824M | +17% | $3,752M | +82% |
| 毛利率 Gross Margin | 26.9% | 18.5% | +8.4 ppt | -17.8% | +44.7 ppt |
| 研发费用 R&D | $850M | $832M | +2% | $758M | +12% |
| 销售及管理 SG&A | $291M | $280M | +4% | $219M | +33% |
| 折旧摊销 D&A | $1,955M | $3,839M | -49% | — | — |
| 股权激励 SBC | $217M | $209M | +4% | $148M | +47% |
| 营业利润 Operating Income | $719M | $191M | +276% | -$1,761M | +141% |
| 利息费用 Interest Expense | $150M | $144M | +4% | $119M | +26% |
| 净利润 Net Income | $332M | $793M | -58% | -$1,896M | +118% |
| 指标 | Q3 FY2024 | Q2 FY2024 | Q/Q | Q3 FY2023 | Y/Y |
|---|---|---|---|---|---|
| 每股收益 EPS | $0.30 | $0.71 | -58% | -$1.73 | +117% |
| 稀释股数 Diluted Shares | 1,123M | 1,114M | +1% | 1,094M | +3% |
| 实际税率 Effective Tax Rate | 52.7% | -3.7% | +56.4 ppt | -7.9% | +60.6 ppt |
| 板块 | 收入 | 占比 | QoQ | YoY |
|---|---|---|---|---|
| DRAM | $4,692M | 68.9% | +13% | +76% |
| NAND | $2,065M | 30.3% | +32% | +104% |
| Other | $54M | 0.8% | -45% | -19% |
| 板块 | 收入 | 占比 | QoQ | YoY |
|---|---|---|---|---|
| CNBU | $2,573M | 37.8% | — | +85% |
| MBU | $1,588M | 23.3% | — | +94% |
| EBU | $1,294M | 19.0% | — | +42% |
| SBU | $1,353M | 19.9% | — | +116% |
| 板块 | 收入 | 占比 | QoQ | YoY |
|---|---|---|---|---|
| Largest Distributor (9mo) | $0M | 0.0% | — | — |
One distributor was 11% of 9-month FY2024 revenue. No single customer >10% in Q3 FY2023.
Not disclosed in 10-Q filing
本季度数据
| 指标 | Q3 FY2024 | Q2 FY2024 | 变化 |
|---|---|---|---|
| 暂无动态指标配置 | |||
以下观点摘自 10-Q MD&A 管理层讨论章节
"需求增长加速（部分受AI部署驱动）叠加客户库存基本正常化，加上行业供给纪律，推动供需平衡改善。"
"我们在大批量制造节点上已满负荷运转，在结构性降低的产能基础上最大化产出。"
"Q3 FY2024 DRAM销售同比增长76%，主要受ASP和出货位元均增长约30%中段驱动。"
"Q3 FY2024 NAND销售同比增长104%，主要受ASP增长约60%低段和出货位元增长约20%高段驱动。"
| 指标 | 数值 | 备注 |
|---|---|---|
| asp_trend_dram_yoy_q3 | +mid-30% YoY | DRAM ASP per MD&A for Q3 FY2024 vs Q3 FY2023 |
| asp_trend_nand_yoy_q3 | +low-60% YoY | NAND ASP per MD&A for Q3 FY2024 vs Q3 FY2023 |
| bit_growth_dram_yoy_q3 | +mid-30% YoY | DRAM bit shipments per MD&A for Q3 FY2024 vs Q3 FY2023 |
| bit_growth_nand_yoy_q3 | +high-20% YoY | NAND bit shipments per MD&A for Q3 FY2024 vs Q3 FY2023 |
| customer_prepayments | $756M | Customer prepayments to secure product supply, of which $615M in other current liabilities |
| nrv_benefit_9mo | $987M | Lower costs from sale of inventory previously written down to NRV, nine months FY2024 |
| patent_cross_license_gain | $200M | Patent cross-license agreement gain recognized in nine months FY2024 |
| netlist_verdict | $445M | Jury verdict ($425M + $20M) for patent infringement by Netlist; Micron expects to appeal. PTAB found key patent unpatentable. |
| chips_act_funding | Up to $6.1B direct + $7.5B loans | Non-binding preliminary memorandum with U.S. Dept of Commerce for Boise and Clay, NY fabs |
| capex_guidance_fy2024 | ~$8.0B net of govt incentives | FY2024 CapEx estimate from MD&A |
| consideration_payable_prior | $453M | Consideration payable to customers as of Aug 31, 2023, for comparison |